The CVRM-Box significantly reduced systolic blood pressure by 5.5 mmHg, decreased weight by 0.9 kg, and increased antihypertensive use in high-risk CVD patients.
Does remote monitoring using connected devices improve blood pressure control, weight management, and healthcare utilization in primary care patients at high risk of cardiovascular disease?
Remote monitoring in high-risk primary care patients improves home blood pressure control, weight management, and medication optimization while reducing the frequency of clinical consultations.
Absolute Event Rate: 0% vs 0%
Abstract Aims This study aimed to evaluate the effect of remote monitoring using the Cardiovascular Risk Management (CVRM)-Box on blood pressure control, weight management, medication prescriptions, and consultation frequency in primary care patients at high risk of cardiovascular disease (CVD). Methods and Results In this matched cohort study, patients with a 5% 10-year CVD mortality risk in primary care (2020–2024) were compared to propensity score-matched controls over 12 months. The CVRM-Box included smartphone-connected devices (blood pressure monitor, weighing scale, activity tracker) linked to general practitioner electronic health records. Compared to controls, the intervention group showed modest reductions in office-measured systolic (-1.1 mmHg 95% CI, -3.7 to -1.5; p = 0.39) and diastolic blood pressure (-0.04 mmHg 95% CI, -1.6 to 1.5; p = 0.96). Sensitivity analyses yielded similar results. However, CVRM-Box assessments showed reductions in systolic (-5.5 mmHg 95% CI, -7.6 to -3.3; p 0.001) and diastolic blood pressure (-3.8 mmHg 95% CI, -5.1 to -2.4; p 0.001). The intervention group also experienced greater reductions in weight (-0.9 kg 95% CI, -1.6 to -0.2; p = 0.01) and BMI (-0.3 kg/m² 95% CI, -0.5 to -0.01; p =0.007). Additionally, antihypertensive medication use increased (0.12 95% CI, 0.06 to 0.23; p = 0.04), while consultation frequency decreased (rate ratio 0.82; p = 0.002). Conclusions While office measurements showed no additional blood pressure reduction, CVRM-Box measurements demonstrated significant decreases. The intervention also improved target blood pressure achievement, promoted weight reduction, increased antihypertensive use, and reduced consultation frequency.
Hattem et al. (Wed,) reported a other. The CVRM-Box significantly reduced systolic blood pressure by 5.5 mmHg, decreased weight by 0.9 kg, and increased antihypertensive use in high-risk CVD patients.